PGNX
Progenics Pharmaceuticals Inc
PGNX
PGNX
Delisted
PGNX was delisted on the 19th of June, 2020.
78 hedge funds and large institutions have $293M invested in Progenics Pharmaceuticals Inc in 2014 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 21 increasing their positions, 26 reducing their positions, and 13 closing their positions.
Holders
78
Holders Change
+2
Holders Change %
+2.63%
% of All Funds
2.26%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
15
Increased
21
Reduced
26
Closed
13
Calls
$1.33M
Puts
$1.11M
Net Calls
+$222K
Net Calls Change
+$55K
Top Buyers
1 |
BC
1
Broadfin Capital
New York
|
$46.5M |
2 |
TM
2
Tiger Management
New York
|
$6.7M |
3 |
![]()
3
Fidelity Investments
Boston,
Massachusetts
|
$26.2M |
4 |
RA
4
Royce & Associates
New York
|
$3.53M |
5 |
FM
5
Forward Management
San Francisco,
California
|
$3.01M |